• FAQ
  • Glossary
Fermer

FAQ

What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Voir toutes les FAQ

Fermer

Glossary

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

Voir le glossaire complet

Retour à l'index du glossaire

Accelerated assessment

Procedure to reduce the time of assessment of the marketing authorisation application (from 210 to 150 days) for medicines targeting an unmet medical need.

Read related content in the entries on commercialisation of the research pathways.

Retour en haut de page
Le contenu de cette page vous a-t-il été utile ? Envoyez-nous vos commentaires